{
  "id": 6898149,
  "title": "Local consolidative therapy does not improve survival after dual immunotherapy in metastatic NSCLC",
  "url": "https://urgent.news/2026/09/12/local-consolidative-therapy-does-not-improve-survival-after-dual",
  "topic": "science",
  "section": "Science",
  "published": "2026-09-12T09:20:06.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-09-local-therapy-survival-dual-immunotherapy.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Adding local consolidative therapy (LCT) after induction treatment with nivolumab plus ipilimumab did not improve overall survival or progression-free survival in patients with metastatic non-small cell lung cancer (NSCLC), including those with oligometastatic disease, according to results presented at the International Association for the Study of Lung Cancer (IASLC) 2026 World Conference on…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Medical Xpress",
        "title": "Perioperative atezolizumab + chemotherapy more than doubles event-free survival in resectable stage II–IIIB NSCLC",
        "url": "https://urgent.news/2026/09/12/perioperative-atezolizumab-chemotherapy-more-than-doubles-event-free",
        "published": "2026-09-12T09:20:08.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}